The present study investigated the prognostic factors predicting survival of patients with sepsis and acute kidney injury (AKI) undergoing continuous renal replacement therapy (CRRT). This retrospective observational study included 165 sepsis patients treated with CRRT. The patients were divided into two groups; the survivor group (n=73, 44.2%) vs. the nonsurvivor group (n=92, 55.8%). AKI was defined by the 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guidelines. We analyzed medical histories, clinical characteristics and laboratory findings of the enrolled patients when they started CRRT. In addition, we performed binary logistic regression and cox regression analysis. In the survivor group, urine output during the first day was significantly higher compared with the nonsurvivor group (55.7±66.3 vs. 26.6± 46.4, p=0.001). Patients with urine output ＜30 mL/hour during the 1st day showed worse outcomes than ≥30 mL/hour in the logistic regression (hazard ratio 2.464, 95% confidence interval 1.152-5.271, p=0.020) and the cox regression analysis (hazard ratio 1.935, 95% confidence interval 1.147-3.263, p=0.013). In conclusion, urine output may predict survival of septic AKI patients undergoing CRRT. In these patients, urine output ＜30 mL/hour during the first day was the strongest risk factor for in-hospital mortality.
INTRODUCTION
Sepsis is a systemic inflammatory reaction, and may proceed to multiple organ failure including acute kidney injury (AKI). [1] [2] [3] In critically ill patients, sepsis is closely associated with in-hospital mortality. [4] [5] [6] [7] Hospital mortality was significantly increased when AKI developed in intensive care unit (ICU) patients. [8] [9] [10] [11] Furthermore, septic AKI patients had a poorer prognosis than non-septic AKI patients. 12 For early diagnosis and treatment of AKI, Acute Kidney Injury Network (AKIN) and Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) criteria have been validated for diagnosis of AKI. 13 Recently, AKI has been defined by the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines.
14 These definitions based on serum creatinine and urine output as surrogates for changes of glomerular filtration rate (GFR). Increased stage AKI is associated with in-hospital mortality. [15] [16] [17] Previous studies have also demonstrated that the mortality of critically ill patients was associated with the increased level of serum creatinine or oliguria. 18 owever, clinical biomarkers predicting survival of septic AKI undergoing continuous renal replacement therapy (CRRT) have not yet been established although several biomarkers have been investigated. [19] [20] [21] The present study investigated the prognostic factors predicting survival of septic AKI patients undergoing CRRT.
MATERIALS AND METHODS
This retrospective observational study included 165 patients with AKI and sepsis treated with CRRT between December 2012 and August 2015. The patients were divided into two groups; the survivor group (n=73, 44.2%) vs. the nonsurvivor group (n=92, 55.8%). We defined sepsis as systemic inflammatory response syndrome (SIRS) in re- (14.5) 18 (24.7) 6 (6.5) Colitis, n (%) 15 (9.1) 10 (13.7) 5 (5.4) Peritonitis, n (%) 10 (6.1) 3 (4.1) 7 (7.6) Any abscess, n (%) 8 (4.8) sponse to an infectious process. 22 AKI was defined by the 2012 KDIGO Clinical Practice Guideline. 14 We analyzed medical histories, clinical characteristics and laboratory findings of the enrolled patients when they started CRRT. Categorical variables were analyzed using the Chi-square test. Parametric variables were expressed as the mean± standard deviation, and analyzed by the unpaired t-test. Binary logistic regression and cox regression analysis after adjusting for age, sex, and medical histories were also performed. Differences with values of p＜0.05 were considered statistically significant.
RESULTS
The clinical characteristics of the enrolled patients were summarized in Table 1 . Of 165 patients, 92 patients (55.8%) died during hospitalization. Sex, age and underlying diseases did not differ between the survivor and nonsurvivor groups, but the simplified acute physiologic score 3 (SAPS 3) was significantly higher in the nonsurvivor group. The most common cause of sepsis was pneumonia in all of the patients in both the survivor and nonsurvivor groups ( Table 2 ). The laboratory findings at starting CRRT and urine output during the first day were shown in Table 3 . In the survivor group, urine output during the first day was significantly higher compared with the nonsurvivor group (55.7±66.3 vs. 26.6±46.4, p=0.001). However, serum creatinine levels did not differ between the groups. White blood cell counts and platelet counts were lower but the total bilirubin level was higher in the nonsurvivor group compared with the survivor group. The value of the pH was lower in the nonsurvivor group although the bicarbonate level and anion gap did not differ between the two groups. Table 4 demonstrated the results of the logistic regression analysis of risk factors for mortality in septic AKI patients with CRRT. The urine output ＜30 mL/hour during the 1st day was the strongest risk factor for these patients (hazard ratio 2.464, 95% confidence interval 1.152-5.271, p=0.020). The cox regression analysis also showed that the urine output ＜30 mL/hour during the 1st day was the risk factor for death in the septic AKI patients treated with CRRT (hazard ratio 1.935, 95% confidence interval 1.147-3.263, p=0.013) ( Table 5 ). In the survival analysis, patients with urine outputs of ≥30 mL/hour during the 1st day showed better outcomes than those at ＜30 mL/hour (Fig. 1) .
DISCUSSION
There are several studies working to predict the survival of the patients treated with CRRT. One of studies revealed that nonoliguria, shorter durations of CRRT, and higher baseline estimated GFR were independently associated with favorable outcomes. 23 Another study demonstrated that urine output was the most important predictor of weaning from CRRT although serum creatinine was also a significant factor. 24 However, the independent risk factors for early kidney recovery were urine output, duration between ICU admission to CRRT initiation and sepsis-related organ failure assessment score, but serum creatinine level did not affect the renal outcome in AKI requiring CRRT although the definitions of AKI such as AKIN, RIFLE criteria and the 2012 KDIGO Clinical Practice Guidelines primarily based on serum creatinine as a biomarker for GFR. 25 Similar results were also demonstrated in the studies of AKI patients who underwent acute RRT. 26, 27 The present study included 165 patients with AKI and sepsis who underwent CRRT, and 55.8% of the enrolled patients died regardless of age, sex and underlying diseases. In our study, urine output was significantly higher in the survivor group and decreased urine output was a strong risk factor for death of the septic AKI patients treated with CRRT. Furthermore, the patients with urine output ≥30 mL/hour showed better outcomes. However, serum creatinine levels did not differ between the two groups, and did not predict the survival of septic AKI patient requiring CRRT. Serum creatinine levels may be affected by various clinical factors such as age, gender, muscle mass, volume status, nutritional status and catabolic rate. It was re-ported that a higher level of serum creatinine on initiation of CRRT was paradoxically associated with better outcomes in critically ill patients with AKI. 28 Furthermore, urine output may reflect changes of GFR earlier than serum creatinine. 29 Studies validating urine output as a biomarker of AKI have been also reported. 30 Our results suggest that the use of serum creatinine only to categorize AKI severity may miss the burden of AKI.
In conclusion, urine output may predict survival rates of septic AKI patients undergoing CRRT. In these patients, urine output ＜30 mL/hour during the first 24 hr was a strong risk factor for in-hospital mortality.
